Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Isotretinoin × Clear all

NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00176527 2009-12-11

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Terminated

Prostatic Neoplasms